Advances in the research of plant-derived natural products against retinoblastoma
Author:
Corresponding Author:

Shu-Guang Sun and Cai-Rui Li. School of Clinical Medicine, Dali University, No.22, Wanhua Road, Xiaguan Town, Dali 671000, Yunnan Province, China. sshuglily@163.com; lcrbrett@163.com

Affiliation:

Clc Number:

Fund Project:

Supported by the Scientific Research Fund of Jiangxi Education Department (No.GJJ211224); the Joint Key Project of Yunnan Universities (No.202001BA070001-007).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Retinoblastoma (RB) is a highly aggressive ocular tumor, and due to socioeconomic and medical constraints, many children receive treatment only in the metaphase and advanced clinical stages, resulting in high rates of blindness and disability. Although several approaches exist in the treatment of RB, some children with the disease do not have satisfactory results because of various factors. Plant-derived natural products have shown definite therapeutic effects in the treatment of various tumors and are also widely used in the study of RB. We review plant-derived natural products used in the study of anti-RB to provide ideas for the clinical application of these drugs and the development of new therapeutic drugs.

    Reference
    Related
    Cited by
Get Citation

Jing-Chen Liu, Chun-Li Zhang, Kai-Ye Dong, et al. Advances in the research of plant-derived natural products against retinoblastoma. Int J Ophthalmol, 2022,15(8):1391-1400

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:June 01,2021
  • Revised:November 24,2021
  • Adopted:
  • Online: July 28,2022
  • Published: